Kunio Iwatani
Director/Board Member at MEDRX CO., LTD
Profile
Kunio Iwatani is an Independent Outside Director at Medrx Co., Ltd.
since 2016.
He was previously the President, CEO & Representative Director at Hokuriku Seiyaku Co., Ltd.
He also worked as a Director-International Product Management at Takeda Pharmaceutical Co., Ltd., Director at Abbott Japan LLC, President & Representative Director at Kringle Pharma, Inc. from 2003 to 2016, and Executive Vice President at TAP Pharmaceutical Products, Inc. Additionally, he served as Vice President at Takeda France SAS.
Kunio Iwatani active positions
| Companies | Position | Start |
|---|---|---|
| MEDRX CO., LTD | Director/Board Member | 2016-02-29 |
Former positions of Kunio Iwatani
| Companies | Position | End |
|---|---|---|
Abbott Japan LLC
 Abbott Japan LLC Drugstore ChainsRetail Trade Abbott Japan LLC manufactures and supplies pharmaceutical medicines. It manufactures medicines for nervous and respiratory agents. The company is headquartered in Tokyo, Japan. | Director/Board Member | - |
Hokuriku Seiyaku Co., Ltd.
 Hokuriku Seiyaku Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Abbott Laboratories, Hokuriku Seiyaku Co., Ltd. develops, manufactures, and sells pharmaceuticals. The private company is based in Katsuyama, Japan. Hokuriku Seiyaku Co. was acquired by Abbott Laboratories on June 30, 2002 for $291.31 million. | Chief Executive Officer | - |
Takeda France SAS
 Takeda France SAS Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda France SAS is a private company based in Paris, France. The CEOs are Anne-Sylvie Brunel, Sonia Rouges. Takeda France specializes in research and development for innovation in health, with expertise in gastroenterology, hematology, oncology, and rare diseases. The French company is committed to promoting information and studies requiring access to data by health manufacturers. Takeda France also has initiatives for diversity, equity, and inclusion, as well as a policy for the protection of personal data. The company was founded in 1978. | Corporate Officer/Principal | - |
TAP Pharmaceutical Products, Inc.
 TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| MEDRX CO., LTD | Health Technology |
| KRINGLE PHARMA, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Hokuriku Seiyaku Co., Ltd.
Hokuriku Seiyaku Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Abbott Laboratories, Hokuriku Seiyaku Co., Ltd. develops, manufactures, and sells pharmaceuticals. The private company is based in Katsuyama, Japan. Hokuriku Seiyaku Co. was acquired by Abbott Laboratories on June 30, 2002 for $291.31 million. | Health Technology |
Abbott Japan LLC
Abbott Japan LLC Drugstore ChainsRetail Trade Abbott Japan LLC manufactures and supplies pharmaceutical medicines. It manufactures medicines for nervous and respiratory agents. The company is headquartered in Tokyo, Japan. | Retail Trade |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Health Technology |
Takeda France SAS
Takeda France SAS Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda France SAS is a private company based in Paris, France. The CEOs are Anne-Sylvie Brunel, Sonia Rouges. Takeda France specializes in research and development for innovation in health, with expertise in gastroenterology, hematology, oncology, and rare diseases. The French company is committed to promoting information and studies requiring access to data by health manufacturers. Takeda France also has initiatives for diversity, equity, and inclusion, as well as a policy for the protection of personal data. The company was founded in 1978. | Health Technology |
- Stock Market
- Insiders
- Kunio Iwatani
